General Information of Drug (ID: DM4XPCR)

Drug Name
B1-655075
Indication
Disease Entry ICD 11 Status REF
Coagulation defect 3B10.0 Phase 1 [1]
Cross-matching ID
TTD ID
D0X0FW

References

1 Clinical pipeline report, company report or official report of Boehringer Ingelheim Pharmaceuticals.